1 min read
Novartis Sets 5% Annual Net Sales Growth Target Through 2031
The foreign exchange-adjusted target covers 2026 to 2031. Novartis shares fell in Zurich after the company updated its midterm outlook.

Novartis set a foreign exchange-adjusted target for net sales to grow at a 5% compound annual rate from 2026 through 2031, while its shares fell in Zurich after the Swiss drugmaker updated its midterm outlook on Nov. 19.